Equity Sector Funds Very High Risk
The primary investment objective of the scheme is to seek to generate consistent returns by
predominantly investing in equity and equity related securities of pharmaceutical and healthcare
companies.
Expert-managed portfolios tailored to your financial goals.
Estimation is based on the past performance
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | 8.21% | 4.38% | -0.83% | -4.8% | 4.87% | 9.37% | 21.77% | 15.78% | 13.64% | 0% | 20.1% |
| Category returns | 6.83% | 7.45% | 0.03% | -2.3% | 6.38% | 11.92% | 22.96% | 16.06% | 13.74% | 12.95% | N/A |
| Absolute returns | 6.52% | 7.89% | 2.62% | 1.53% | 9.62% | 23.48% | 86.76% | 99.41% | 96.35% | 0% | 305.79% |
| Rank within category | 3 | 17 | 12 | 15 | 11 | 11 | 8 | 6 | 5 | 5 | N/A |
| Total Schemes in Category | 18 | 18 | 17 | 17 | 16 | 14 | 10 | 10 | 9 | 4 | N/A |
| Sector Funds | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Yearly returns | N/A | 7.69% | 76.9% | 23.3% | -7.79% | 35% | 40.69% | -5.81% | 3.5% |
| Q1 returns | N/A | 2.99% | -0.76% | -0.61% | -7.96% | -4.59% | 10.74% | -10.15% | -7.8% |
| Q2 returns | N/A | -6.02% | 26.17% | 13.2% | -11.9% | 14.7% | 1.88% | 4.31% | 12.26% |
| Q3 Returns | N/A | 1.07% | 28.85% | 7.5% | 9.13% | 9.6% | 22.29% | -1.3% | N/A |
| Q4 Returns | N/A | 10.07% | 9.65% | 1.95% | 4.21% | 12.55% | 1.97% | 1.83% | N/A |
Expense ratio: N/A
Inclusive of GST
Exit load
0.50% on or before 1M, Nil after 1M
| Alpha | 0.996501 |
| Beta | 0.6398 |
| Sharpe Ratio | 0.31998 |
| Sortino Ratio | 0.713234 |
| R-Squared | 0.3061 |
| Tracking Error | 3.5972 |
| Downside Risk | 15.5968 |
| Std. Deviation (Annualised) | 14.0169 |
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Expense Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth | 9.18% | 6.67% | -0.99% | -3.59% | 7.1% | 27.02% | 16.23% | 0% | 19.44% | 6,293.14 | 1.87 | 0.39 | Very High |
| UTI Healthcare Fund - Regular Plan - IDCW | 7.91% | 7.54% | 0.1% | -2.35% | 8.33% | 24.87% | 13.99% | 12.81% | 14.66% | 1,055.53 | 2.28 | 0.35 | Very High |
| SBI Healthcare Opportunities Fund - Regular Plan - IDCW | 5.71% | 8.21% | 0.45% | -1.13% | 4.56% | 24.83% | 15.56% | 12.3% | 16.26% | 4,063.64 | 1.93 | 0.37 | Very High |
| Mirae Asset Healthcare Fund - Regular Plan - Growth | 6.15% | 10.25% | 3.03% | 0.11% | 9.4% | 23.81% | 14.41% | 0% | 19.42% | 2,753.72 | 1.94 | 0.34 | Very High |
| Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth | 4.7% | 6.4% | 1.22% | -1.71% | 5.37% | 22.75% | 12.57% | 0% | 18.41% | 858.87 | 2.30 | 0.33 | Very High |
| Nippon India Pharma Fund - Growth | 5.58% | 6.09% | 0.67% | -3.68% | 4.04% | 22.1% | 13.33% | 14.48% | 19.73% | 7,898.24 | 1.82 | 0.32 | Very High |
| Tata India Pharma & Healthcare Fund - Regular Plan - Growth | 6.85% | 5.21% | -3.15% | -4.34% | 2.3% | 22.03% | 13.39% | 12.21% | 11.21% | 1,229.42 | 2.15 | 0.30 | Very High |
| DSP Healthcare Fund - Regular Plan - Growth Current | 8.21% | 4.38% | -0.83% | -4.8% | 4.87% | 21.77% | 13.64% | 0% | 20.1% | 2,891.76 | 1.94 | 0.31 | Very High |
| LIC MF Healthcare Fund - Regular Plan - Growth | 7.33% | 7.14% | -1.96% | -3.4% | 4.69% | 20.94% | 10.57% | 0% | 16.19% | 78.30 | 2.36 | 0.29 | Very High |
| ITI Pharma & Healthcare Fund - Regular Plan - Growth | 8.1% | 8.47% | -2.98% | -5.82% | 0.32% | 19.48% | 0% | 0% | 10.95% | 211.30 | 2.35 | 0.25 | Very High |
| Instrument Allocation | Instrument | Assets % |
|---|---|---|
|
|
Domestic Equities | 79.64% |
| Overseas Equities | 17.13% | |
| Cash & Cash Equivalents and Net Assets | 2.39% | |
| Overseas Mutual Fund Units | 0.84% |
| Sector Allocation | Sector | Assets % |
|---|---|---|
| Pharmaceuticals & Biotechnology | 65.94% | |
| Healthcare Equipment & Supplies | 10.13% | |
| Healthcare Services | 18.81% | |
| Others | 2.39% | |
| Insurance | 1.35% | |
| Foreign Security | 0.84% | |
| Retailing | 0.53% |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 8.84% |
| Ipca Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 8.26% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 7.56% |
| Globus Medical Inc | Healthcare Equipment & Supplies | Overseas Equities | 7.35% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 6.42% |
| Illumina Inc | Healthcare Services | Overseas Equities | 6.16% |
| Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 6.10% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.13% |
| Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.83% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 4.73% |
| Alembic Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.43% |
| Vijaya Diagnostic Centre Ltd. | Healthcare Services | Domestic Equities | 3.36% |
| Pfizer Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.01% |
| Kovai Medical Center & Hospital Ltd. | Healthcare Services | Domestic Equities | 2.97% |
| Procter & Gamble Health Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.64% |
| Intuitive Surgical Inc | Healthcare Equipment & Supplies | Overseas Equities | 2.60% |
| TREPS / Reverse Repo Investments | Cash & Cash Equivalents and Net Assets | 2.19% | |
| Indoco Remedies Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.16% |
| Emcure Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.01% |
| Concord Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.81% |
| ICICI Lombard General Insurance Company Ltd. | Insurance | Domestic Equities | 1.35% |
| Nephrocare Health Services Ltd. | Healthcare Services | Domestic Equities | 1.07% |
| Unichem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.06% |
| Aarti Drugs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.02% |
| Abbott Laboratories | Pharmaceuticals & Biotechnology | Overseas Equities | 0.87% |
| Global X Funds - Global X Genomics & Biotechnology ETF | Foreign Security | Overseas Mutual Fund Units | 0.84% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.64% |
| Medplus Health Services Ltd. | Retailing | Domestic Equities | 0.53% |
| Jupiter Life Line Hospitals Ltd. | Healthcare Services | Domestic Equities | 0.37% |
| Net Receivables/Payables | Cash & Cash Equivalents and Net Assets | 0.20% | |
| Laxmi Dental Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.18% |
| CORONA Remedies Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.15% |
| Grail Inc | Healthcare Services | Overseas Equities | 0.14% |
| Total | 100.00% |
RETURNS
It is an Open ended scheme that primarily invests in Sector Funds.
The primary investment objective of the scheme is to seek to generate consistent returns by
predominantly investing in equity and equity related securities of pharmaceutical and healthcare
companies.
The scheme benchmark is the BSE Health Care - TRI
It is classified as Very High Risk, suitable for investors with a Very High risk appetite.
Returns Delivered by the funds are as follows:
1-year: 9.62%
3-year: 23.12%
5-year: 14.44%
Top holdings include names such as:
The NAV is around ₹40.58 (approx.) for the DSP Healthcare Fund - Regular Plan - Growth.
The fund’s AUM is approximately ₹3,142 Cr.
The expense ratio for the Regular Plan is 0.
0.50% on or before 1M, Nil after 1M.
Minimum SIP starts at ₹100.
The minimum lump sum investment is ₹100. Often platforms may require higher in practice, but the statutory minimum remains the same.
You can start a SIP through:
Broker/agent platform like Sharescart.
Enter KYC details, choose the Regular Growth option, set SIP amount/frequency, and submit.
Yes. You can modify your SIP amount or frequency anytime online through the Sharescart platform.
You can redeem online via the Sharescart platform — choose the scheme, select the amount/units, and submit. Proceeds are credited to your bank account.
The fund manager: Chirag Dagli
This fund is suitable for investors with a Very High risk tolerance.
Get personalized Portfolio Management Services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
